These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8033298)

  • 1. Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.
    Walker DL; Reid JM; Ames MM
    Cancer Chemother Pharmacol; 1994; 34(4):317-22. PubMed ID: 8033298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
    Lee CS; Pfeifer GP; Gibson NW
    Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay.
    Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNA minor groove-alkylating cyclopropylpyrroloindole drugs adozelesin and bizelesin induce different DNA damage response pathways in human colon carcinoma HCT116 cells.
    Cao PR; McHugh MM; Melendy T; Beerman T
    Mol Cancer Ther; 2003 Jul; 2(7):651-9. PubMed ID: 12883038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical antitumor activity of bizelesin in mice.
    Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
    Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity.
    Reid JM; Walker DL; Ames MM
    Cancer Chemother Pharmacol; 1996; 38(4):329-34. PubMed ID: 8674155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity.
    Woynarowski JM; Napier C; Trevino AV; Arnett B
    Biochemistry; 2000 Aug; 39(32):9917-27. PubMed ID: 10933811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of the covalent reaction of CC-1065 and analogues with DNA.
    Warpehoski MA; Harper DE; Mitchell MA; Monroe TJ
    Biochemistry; 1992 Mar; 31(9):2502-8. PubMed ID: 1547233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells.
    Volpe DA; Tomaszewski JE; Parchment RE; Garg A; Flora KP; Murphy MJ; Grieshaber CK
    Cancer Chemother Pharmacol; 1996; 39(1-2):143-9. PubMed ID: 8995512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120.
    Walton MI; Goddard P; Kelland LR; Thurston DE; Harrap KR
    Cancer Chemother Pharmacol; 1996; 38(5):431-8. PubMed ID: 8765436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies.
    Schwartz GH; Patnaik A; Hammond LA; Rizzo J; Berg K; Von Hoff DD; Rowinsky EK
    Ann Oncol; 2003 May; 14(5):775-82. PubMed ID: 12702533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.
    Li LH; Kelly RC; Warpehoski MA; McGovren JP; Gebhard I; DeKoning TF
    Invest New Drugs; 1991 May; 9(2):137-48. PubMed ID: 1874598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in sequence selective minor groove DNA effectors.
    Reddy BS; Sharma SK; Lown JW
    Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the antitumor cyclopropylpyrroloindole antibiotic CC-1065 cross-link DNA in tumor cells?
    Skladanowski A; Koba M; Konopa J
    Biochem Pharmacol; 2001 Jan; 61(1):67-72. PubMed ID: 11137711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.
    Pitot HC; Reid JM; Sloan JA; Ames MM; Adjei AA; Rubin J; Bagniewski PG; Atherton P; Rayson D; Goldberg RM; Erlichman C
    Clin Cancer Res; 2002 Mar; 8(3):712-7. PubMed ID: 11895900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the structural role of the linking moieties in the DNA binding of adozelesin.
    Cameron L; Thompson AS
    Biochemistry; 2000 May; 39(17):5004-12. PubMed ID: 10819964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.
    Li LH; DeKoning TF; Kelly RC; Krueger WC; McGovren JP; Padbury GE; Petzold GL; Wallace TL; Ouding RJ; Prairie MD
    Cancer Res; 1992 Sep; 52(18):4904-13. PubMed ID: 1516047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bizelesin, a bifunctional cyclopropylpyrroloindole alkylating agent, inhibits simian virus 40 replication in trans by induction of an inhibitor.
    McHugh MM; Kuo SR; Walsh-O'Beirne MH; Liu JS; Melendy T; Beerman TA
    Biochemistry; 1999 Aug; 38(35):11508-15. PubMed ID: 10471303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cytotoxicity, antitumor activity and sequence selective binding of two pyrazole analogs structurally related to the antitumor agents U-71,184 and adozelesin.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Gambari R; Bianchi N; Passadore M; Ambrosino P; Mongelli N; Cozzi P; Geroni C
    Anticancer Drug Des; 1997 Oct; 12(7):555-76. PubMed ID: 9365502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.